Network pharmacological identification of active compounds and potential actions of Erxian decoction in alleviating menopause-related symptoms

Chinese Medicine (United Kingdom)

Volumn 10, Issue 1, 2015, Pages

  Wang, Shiwei ^a   Tong, Yao ^a   Ng, Tzi Bun ^b   Lao, Lixing ^a   Lam, Jenny Ka Wing ^c   Zhang, Kalin Yanbo ^a   Zhang, Zhang Jin ^a   Sze, Stephen Cho Wing ^a  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b Prince of Wales Hospital   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

1 HYDROXY 3 METHOXY 9,10 ANTHRAQUINONE; 1 HYDROXY 6 HYDROXYMETHYLANTHRACENEQUINONE; 1,2 BIS(4 HYDROXY 3 METHOXYPHENYL)PROPAN 1,3 DIOL; 1,6 DIHYDROXY 5 METHOXY 2 (METHOXYMETHYL) 9,10 ANTHRAQUINONE; 2 HYDROXY 1,5 DIMETHOXY 6 (METHOXYMETHYL) 9,10 ANTHRAQUINONE; 2 HYDROXY 1,8 DIMETHOXY 7 METHOXYMETHYLANTHRACENEQUINONE; 3 (4 HYDROXY 3 METHOXYPHENYL)N[2 (4 HYDROXYPHENYL)ETHYL]ACRYLAMIDE; 8 (3 METHYLBUT 2 ENYL) 2 PHENYL CHROMONE; ALIZARIN 2 METHYLETHER; AMERICANIN A; ANTHRAQUINONE; C HOMOERYTHRINAN, 1,6 DIDEHYDRO 3,15,16 TRIMETHOXY,(3 BETA); CHINESE DRUG; CHRYSERIOL[5,7 DIHYDROXY 2 (4 HYDROXY 3 METHOXYPHENYL)CHROMEN 4 ONE]; CNIDILIN[9 METHOXY 4 (3 METHYLBUT 2 ENOXY)FURO[3,2 G]CHROMEN 7 ONE]; COPTISINE[6,7 DIHYDRO BIS(1,3)BENZODIOXOLO(5,6 A:4',5' G)QUINOLIZINIUM]; COUMAROYLTYRAMINE(N 1,4 COUMAROYLTYRAMINE); DEHYDROTANSHINONE IIA(1,6,6 TRIMETHYL 7H NAPHTHO[5,6 G][1]BENZOXOLE 10,11 DIONE); DELTA 7 DEHYDROSOPHORAMINE; DIMETHYL ETHER; ERXIAN DECOCTION; HIPPEASTRINE[LYCORENAN 7 ONE, 5 HYDROXY 1 METHYL 9,10 [METHYLENEBIS(OXY)],(5ALPHA)]; KAEMPFEROL[3,5,7 TRIHYDROXY 2 (4 HYDROXYPHENYL)CHROMEN 4 ONE]; LUTEOLIN[2 (3,4 DIHYDROXYPHENYL) 5,7 DIHYDROXYCHROMEN 4 ONE]; MAGNOGRANDIOLIDE(6,9 DIHYDROXY 6,9 DIMETHYL 3 METHYLIDENE 3A,4,5,6A,7,8,9A,9B OCTAHYDROAZULENO[5,4 D]FURAN 2 ONE); PHELLOPTERIN[4 METHOXY 9 (3 METHYLBUT 2 ENOXY)FURO[3,2 G]CHROMEN 7 ONE]; PLANT MEDICINAL PRODUCT; QUERCETIN[2 (3,4 DIHYDROXYPHENYL) 3,5,7 TRIHYDROXYCHROMEN 4 ONE]; SKIMMIANIN(4,7,8 TRIMETHOXYFURO[2,3 B]QUINOLINE); UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; CHINESE MEDICINE; DRUG ANALYSIS; DRUG BIOAVAILABILITY; DRUG IDENTIFICATION; DRUG MECHANISM; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; MENOPAUSE RELATED DISORDER; NETWORK PHARMACOLOGICAL ANALYSIS; PROTEIN INTERACTION;

EID: 84937576139     PISSN: None     EISSN: 17498546     Source Type: Journal    
DOI: 10.1186/s13020-015-0051-z     Document Type: Article

References (73)

1. Cloutier CT, Coxworth JE, Hawkes K (2015) Age-related decline in ovarian follicle stocks differ between chimpanzees (Pan troglodytes) and humans. AGE 37:1-9
2. Burger HG, Dudley EC, Robertson DM, Dennerstein L (2002) Hormonal changes in the menopause transition. Recent Prog Horm Res 57:257-276
3. Landgren B-M, Collins A, Csemiczky G, Burger HG, Baksheev L, Robertson DM (2004) Menopause transition: annual changes in serum hormonal patterns over the menstrual cycle in women during a nine-year period prior to menopause. J Clin Endocrinol Metab 89:2763-2769
4. Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG (2000) A prospective population-based study of menopausal symptoms. Obstet Gynecol 96:351-358
5. Matthews KA, Wing RR, Kuller LH, Meilahn EN, Kelsey SF, Costello EJ et al (1990) Influences of natural menopause on psychological characteristics and symptoms of middle-aged healthy women. J Consult Clin Psychol 58:345
6. Avis NE, Stellato R, Crawford S, Johannes C, Longcope C (2000) Is there an association between menopause status and sexual functioning? Menopause 7:297-309
7. Society (2014) TNAM: terminology and statistics. http://www.menopause.org/docs/2012/cg_a.pdf?sfvrsn=2
8. Obermeyer CM, Reher D, Saliba M (2007) Symptoms, menopause status, and country differences: a comparative analysis from DAMES. Menopause 14:788-797
9. NIA: AgePage menopause. 2014. http://www.nia.nih.gov/health/publication/menopause
10. NHS: menopause. 2014. http://www.nhs.uk/conditions/Menopause/Pages/Introduction.aspx
11. Yang D, Haines C, Pan P, Zhang Q, Sun Y, Hong S et al (2008) Menopausal symptoms in mid-life women in southern China. Climacteric 11:329-336
12. Li L, Wu J, Pu D, Zhao Y, Wan C, Sun L et al (2012) Factors associated with the age of natural menopause and menopausal symptoms in Chinese women. Maturitas 73:354-360
13. Li Y, Yu Q, Ma L, Sun Z, Yang X (2008) Prevalence of depression and anxiety symptoms and their influence factors during menopausal transition and postmenopause in Beijing city. Maturitas 61:238-242
14. Investigators WGftWsHI (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-333
15. Santen RJ, Allred DC, Ardoin SP, Archer DF, Boyd N, Braunstein GD et al (2010) Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab 95:1-66
16. Wang CC, Cheng KF, Lo WM, Law C, Li L, Leung PC et al (2013) A randomized, double-blind, multiple-dose escalation study of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) for moderate to severe menopausal symptoms and quality of life in postmenopausal women. Menopause 20:241-249
17. Zhong LL, Tong Y, Tang GW, Zhang ZJ, Choi WK, Cheng KL et al (2013) A randomized, double-blind, controlled trial of a Chinese herbal formula (Er-Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women. Menopause 20:767-776
18. Kang H, Ansbacher R, Hammoud M (2002) Use of alternative and complementary medicine in menopause. Int J Gynaecol Obstet 79:195-207
19. Hunt KJ, Coelho HF, Wider B, Perry R, Hung S, Terry R et al (2010) Complementary and alternative medicine use in England: results from a national survey. Int J Clin Pract 64:1496-1502
20. Posadzki P, Ernst E (2013) Prevalence of CAM use by UK climacteric women: a systematic review of surveys. Climacteric 16:3-7
21. Posadzki P, Lee MS, Moon TW, Choi TY, Park TY, Ernst E (2013) Prevalence of complementary and alternative medicine (CAM) use by menopausal women: a systematic review of surveys. Maturitas 75:34-43
22. Shen XH, Fang ZQ, Wu DX (1995) Effect of er-xian decoction and its disassembled prescription on enzyme activities and their gene expression of antioxidant enzymes in aging rat. Zhongguo Zhong Xi Yi Jie He Za Zhi 15:672-674
23. Dong BF, Fang ZQ, Shi JR (2006) Effect of er xian decoction and its subdivisions on granulosa cells secretory function in rats. Zhongguo Zhong Xi Yi Jie He Za Zhi 26(Suppl):122-125
24. Nian H, Qin LP, Zhang QY, Zheng HC, Yu Y, Huang BK (2006) Antiosteoporotic activity of Er-Xian Decoction, a traditional Chinese herbal formula, in ovariectomized rats. J Ethnopharmacol 108:96-102
25. Lu XN, Xu XR, Lin LJ (2008) Clinical observation of bushen er'xian decoction in treating premature ovarian failure. Zhongguo Zhong Xi Yi Jie He Za Zhi 28:594-596
26. Qin L, Han T, Zhang Q, Cao D, Nian H, Rahman K et al (2008) Antiosteoporotic chemical constituents from Er-Xian Decoction, a traditional Chinese herbal formula. J Ethnopharmacol 118:271-279
27. Wu C, Zhang J, Zhou T, Guo B, Wang Y, Hou J (2011) Simultaneous determination of seven flavonoids in dog plasma by ultra-performance liquid chromatography-tandem mass spectrometry and its application to a bioequivalence study of bioactive components in Herba Epimedii and Er-Xian Decoction. J Pharm Biomed Anal 54:186-191
28. Xue L, Wang Y, Liu L, Zhao L, Han T, Zhang Q et al (2011) A HNMR-based metabonomics study of postmenopausal osteoporosis and intervention effects of Er-Xian Decoction in ovariectomized rats. Int J Mol Sci 12:7635-7651
29. Xue L, Jiao L, Wang Y, Nie Y, Han T, Jiang Y et al (2012) Effects and interaction of icariin, curculigoside, and berberine in er-xian decoction, a traditional chinese medicinal formula, on osteoclastic bone resorption. Evid Based Complement Alternat Med 2012:490843
30. Xue L, Wang Y, Jiang Y, Han T, Nie Y, Zhao L et al (2012) Comparative effects of er-xian decoction, epimedium herbs, and icariin with estrogen on bone and reproductive tissue in ovariectomized rats. Evid Based Complement Alternat Med 2012:241416
31. Wong KC, Lee KS, Luk HK, Wan HY, Ho CK, Zhang Y et al (2014) Er-xian Decoction exerts estrogen-like osteoprotective effects in vivo and in vitro. Am J Chin Med 42:409-426
32. Zhu Z, Xue LM, Han T, Jiao L, Qin LP, Li YS et al (2010) Antiosteoporotic effects and proteomic characterization of the target and mechanism of an Er-Xian Decoction on osteoblastic UMR-106 and osteoclasts induced from RAW264.7. Molecules 15:4695-4710
33. Yang Y, Chen MD, Li FY, Tang JF, Gao GF, Chen JL (2001) Effects of "two fairy decoction" and its decomposed recipe on gonadotropin-releasing hormone secreted by GT1-7 cell line. Int Trad Chin West Med Pract Crit Care Med 8:143-145
34. Do W (2009) 40 Cases of clinical observation: the treatment of urinary tract infection by Erxian Decoction. Med Inform 22:1017-1018
35. Sze SC, Tong Y, Zhang YB, Zhang ZJ, Lau AS, Wong HK et al (2009) A novel mechanism: Erxian Decoction, a Chinese medicine formula, for relieving menopausal syndrome. J Ethnopharmacol 123:27-33
36. Hopkins AL (2008) Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 4:682-690
37. Hopkins AL (2007) Network pharmacology. Nat Biotech 25:1110-1111
38. Liang XJ, Li HY, Li S (2014) A novel network pharmacology approach to analyse traditional herbal formulae: the Liu-Wei-Di-Huang pill as a case study. Mol BioSyst 10:1014-1022
39. Azmi AS (2012) Network pharmacology for cancer drug discovery: are we there yet? Future Med Chem 4:939-941
40. Zhang GB, Li QY, Chen QL, Su SB (2013) Network pharmacology: a new approach for chinese herbal medicine research. Evid Based Complement Alternat Med 2013:621423
41. Zhao J, Jiang P, Zhang W (2010) Molecular networks for the study of TCM pharmacology. Brief Bioinform 11:417-430
42. Glaab E, Baudot A, Krasnogor N, Schneider R, Valencia A (2012) EnrichNet: network-based gene set enrichment analysis. Bioinformatics 28:i451-i457
43. Winterhalter C, Widera P, Krasnogor N (2014) JEPETTO: a Cytoscape plugin for gene set enrichment and topological analysis based on interaction networks. Bioinformatics 30:1029-1030
44. Huang DW, Sherman BT, Lempicki RA (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37:1-13
45. Hu YM, Su GH, Sze SC, Ye W, Tong Y (2010) Quality assessment of Cortex Phellodendri by high-performance liquid chromatography coupled with electrospray ionization mass spectrometry. Biomed Chromatogr 24:438-453
46. Hu YM, Wang YT, Sze SC, Tsang KW, Wong HK, Liu Q et al (2010) Identification of the major chemical constituents and their metabolites in rat plasma and various organs after oral administration of effective Erxian Decoction (EXD) fraction by liquid chromatography-mass spectrometry. Biomed Chromatogr 24:479-489
47. Da Wei Huang BTS, Lempicki RA (2008) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57
48. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2012) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 64:4-17
49. Ursu O, Rayan A, Goldblum A, Oprea TI (2011) Understanding drug-likeness. Wiley Interdiscip Rev Comput Mol Sci 1:760-781
50. Xu X, Zhang W, Huang C, Li Y, Yu H, Wang Y et al (2012) A novel chemometric method for the prediction of human oral bioavailability. Int J Mol Sci 13:6964-6982
51. Tao W, Xu X, Wang X, Li B, Wang Y, Li Y et al (2013) Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease. J Ethnopharmacol 145:1-10
52. Wang X, Xu X, Tao W, Li Y, Wang Y, Yang L (2012) A systems biology approach to uncovering pharmacological synergy in herbal medicines with applications to cardiovascular disease. Evid Based Complement Alternat Med 2012:1-15
53. Kuhn M, Szklarczyk D, Pletscher-Frankild S, Blicher TH, von Mering C, Jensen LJ et al (2014) STITCH 4: integration of protein-chemical interactions with user data. Nucleic Acids Res 42:401-407
54. Dai W, Chen J, Lu P, Gao Y, Chen L, Liu X et al (2013) Pathway pattern-based prediction of active drug components and gene targets from H1N1 influenza's treatment with Maxingshigan-Yinqiaosan formula. Mol BioSyst 9:375-385
55. Wu JM, Zelinski MB, Ingram DK, Ottinger MA (2005) Ovarian aging and menopause: current theories, hypotheses, and research models. Exp Biol Med 230:818-828
56. Kelsey JL, Gammon MD, John EM (1993) Reproductive factors and breast cancer. Epidemiol Rev 15:36
57. Dosi R, Bhatt N, Shah P, Patell R (2014) Cardiovascular disease and menopause. J Clin Diagn Res 8:62
58. Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, Rocca WA (2010) Premature menopause or early menopause: long-term health consequences. Maturitas 65:161-166
59. Zhang AH, Sun H, Yang B, Wang XJ (2012) Predicting new molecular targets for rhein using network pharmacology (retracted article. See vol. 8, 105, 2014). BMC Syst Biol 6
60. Bhadra K, Kumar GS (2011) Interaction of berberine, palmatine, coralyne, and sanguinarine to quadruplex DNA: a comparative spectroscopic and calorimetric study. Biochim Biophys Acta 1810:485-496
61. Yu X, Tong Y, Kwok HF, Sze SC, Zhong L, Lau CB et al (2012) Anti-angiogenic activity of Erxian Decoction, a traditional Chinese herbal formula, in zebrafish. Biol Pharm Bull 35:2119-2127
62. Sze SC, Cheung HP, Ng TB, Zhang ZJ, Wong KL, Wong HK et al (2011) Effects of Erxian decoction, a Chinese medicinal formulation, on serum lipid profile in a rat model of menopause. Chin Med 6:40
63. Xu L, Sun L, Lu L, Zhong X, Ma Y, Qin J (2014) Effects of quercetin on CYP450 and cytokines in aroclor 1254 injured endometrial cells of the pregnant rats. BioMed Res Int 2014:497-508
64. Hsu S-C, Chung J-G (2012) Anticancer potential of emodin. BioMedicine 2:108-116
65. West DB, Delany JP, Camet PM, Blohm F, Truett AA, Scimeca J (1998) Effects of conjugated linoleic acid on body fat and energy metabolism in the mouse. Am J Physiol 275:R667-R672
66. Bleijerveld OB, Houweling M, Thomas MJ, Cui Z (2006) Metabolipidomics: profiling metabolism of glycerophospholipid species by stable isotopic precursors and tandem mass spectrometry. Anal Biochem 352:1-14
67. Sampath H, Ntambi JM (2005) Polyunsaturated fatty acid regulation of genes of lipid metabolism. Annu Rev Nutr 25:317-340
68. Alves Martins D, Rocha F, Martínez-Rodríguez G, Bell G, Morais S, Castanheira F et al (2012) Teleost fish larvae adapt to dietary arachidonic acid supply through modulation of the expression of lipid metabolism and stress response genes. Br J Nutr 108:864-874
69. Wahli W, Michalik L (2012) PPARs at the crossroads of lipid signaling and inflammation. Trends Endocrinol Metab 23:351-363
70. Chen R, Alvero AB, Silasi DA, Mor G (2007) Inflammation, cancer and chemoresistance: taking advantage of the toll-like receptor signaling pathway. Am J Reprod Immunol 57:93-107
71. Fritz JH, Ferrero RL, Philpott DJ, Girardin SE (2006) Nod-like proteins in immunity, inflammation and disease. Nat Immunol 7:1250-1257
72. Field KA, Holowka D, Baird B (1995) Fc epsilon RI-mediated recruitment of p53/56lyn to detergent-resistant membrane domains accompanies cellular signaling. Proc Natl Acad Sci 92:9201-9205
73. Chu ES, Sze SC, Cheung HP, Liu Q, Ng TB, Tong Y (2013) An in vitro and in vivo investigation of the antimetastatic effects of a Chinese medicinal decoction, erxian decoction, on human ovarian cancer models. Integr Cancer Ther 12:336-346